Please login to the form below

Not currently logged in
Email:
Password:

Flu vaccine subsidy for Takeda

Takeda Pharmaceutical is to receive a 23.9bn Yen subsidy from the Japanese government as part of a scheme to support the development and production of new influenza vaccines

Takeda Pharmaceutical is to receive a 23.9bn Yen (€215m) subsidy from the Japanese government as part of a scheme to support the development and production of new influenza vaccines.

The company's current influenza-related projects include an agreement with Baxter International to develop the proprietary Vero cell culture-based influenza vaccine technology.

Takeda has already introduced the technology into its experimental production facilities Hikari City having received a similar subsidy in 2010.

The extra funding will enable Takeda to continue the development work it had commenced and make preparations for full-scale manufacturing, including constructing a commercial production facility at the Hikari plant.

A new drug approval for an influenza vaccine is expected by the end of the financial year 2013, according to Takeda.

23rd August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics